284 related articles for article (PubMed ID: 33909805)
1. BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
Queiroz NSF; Teixeira FV; Freire CCF; Motta MP; Vasconcellos MAM; Chebli LA; Saad-Hossne R;
Arq Gastroenterol; 2021; 58(1):1-4. PubMed ID: 33909805
[TBL] [Abstract][Full Text] [Related]
2. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
Bekic D; Belosic Halle Z
Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.
Dalal RS; McClure E; Marcus J; Winter RW; Hamilton MJ; Allegretti JR
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1730-1732.e2. PubMed ID: 33549869
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
Ramos L; Carrillo-Palau M; Alonso-Abreu I; Reygosa C; Hernández-Alvarez N; Amaral C; Hernández A; Benítez-Zafra F; Pérez-González F; Quintana-Díaz H; Hernandez-Guerra M
Gastroenterol Hepatol; 2023 Apr; 46(4):255-260. PubMed ID: 35609791
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 vaccines, where do we stand?
Fischer A
C R Biol; 2021 Jun; 344(1):43-55. PubMed ID: 34213848
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.
Elkharsawi A; Arnim UV; Schmelz R; Sander C; Stallmach A; Teich N; Walldorf J; Reuken PA
Z Gastroenterol; 2022 Jan; 60(1):77-80. PubMed ID: 35042256
[TBL] [Abstract][Full Text] [Related]
8. Bhutan's COVID-19 Vaccination Efforts and the Evolution of COVID-19 Cases in the Aftermath.
Gyeltshen D; Dema T; Ahmadi A; Lucero-Prisno DE
Asia Pac J Public Health; 2022 Jan; 34(1):125-127. PubMed ID: 34670431
[TBL] [Abstract][Full Text] [Related]
9. Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
Ellul P; Revés J; Abreu B; Chaparro M; Gisbert JP; Allocca M; Fiorino G; Barberio B; Zingone F; Pisani A; Cassar D; Michalopoulos G; Mantzaris G; Koutroubakis I; Karmiris K; Katsanos K; Ďuricova D; Burisch J; Madsen GR; Maaser C; Naila A; Orfanoudaki E; Milivojevic V; Buisson A; Avedano L; Leone S; Torres J
J Crohns Colitis; 2022 Aug; 16(7):1070-1078. PubMed ID: 35037033
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
Wellens J; Colombel JF; Satsangi JJ; Wong SY
J Crohns Colitis; 2021 Aug; 15(8):1376-1386. PubMed ID: 33721882
[TBL] [Abstract][Full Text] [Related]
11. Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic.
Doherty J; Fennessy S; Stack R; O' Morain N; Cullen G; Ryan EJ; De Gascun C; Doherty GA
Aliment Pharmacol Ther; 2021 Nov; 54(9):1110-1123. PubMed ID: 34472643
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Klimek L; Chaker AM; Cuevas M
Laryngorhinootologie; 2021 Mar; 100(3):168-173. PubMed ID: 33482671
[TBL] [Abstract][Full Text] [Related]
14. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
Caldera F; Balzora S; Hayney MS; Farraye FA; Cross RK
Inflamm Bowel Dis; 2021 Oct; 27(10):1703-1705. PubMed ID: 34013958
[TBL] [Abstract][Full Text] [Related]
15. T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease.
Reuken PA; Andreas N; Grunert PC; Glöckner S; Kamradt T; Stallmach A
J Crohns Colitis; 2022 Feb; 16(2):251-258. PubMed ID: 34379729
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F
J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV2 Outbreak: Emergence, transmission and clinical features of human coronaviruses.
Imran M; Yasmeen R
J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S710-S713. PubMed ID: 33754539
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
Klimek L; Chaker AM; Cuevas M; Becker S
Laryngorhinootologie; 2021 Aug; 100(8):603-607. PubMed ID: 34044465
[TBL] [Abstract][Full Text] [Related]
19. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
20. Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.
Hudhud D; Caldera F; Cross RK
Inflamm Bowel Dis; 2022 Mar; 28(3):492-493. PubMed ID: 34559239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
